Pfizer and its German partner BioNTech on Tuesday won their attempt to invalidate two of rival CureVac's patents at London's ...

Here, doctors explain which COVID-19 vaccine is better when comparing Moderna, Pfizer, and Novovax. Plus, the efficacy of ...

U.S. sales of RSV vaccines from GSK and Pfizer are down significantly after regulators narrowed the targeted age group and ...

The two companies brought legal action over a repeated sequence in the messenger RNA (mRNA) used in CureVac's patents in life ...

Since COVID was first reported in December 2019, there have been more than 775 million recorded infections and more than 7 ...

A trade group representing large compounding pharmacies sued the FDA over its removal of a widely prescribed Lilly diabetes ...

Since COVID was first reported in December 2019, there have been more than 775 million recorded infections and more than 7 ...

Pfizer and BioNTech successfully invalidated two CureVac patents at London's High Court. The lawsuit filed in September 2022 ...

PFE obtains $1 billion from activist investor Starboard Value. Stock gains on hopes of a plausible turnaround of the ...

The drugmaker has cut costs already and has no coming product approvals or research that could offer a quick lift.

Later on Monday, the Israel Defense Forces (IDF) said that its air force targeted more than 120 Hezbollah sites in southern ...